奥翔药业 (603229.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

股本结构(奥翔药业)

类型/截止日期 2023-02-032022-06-212022-05-272020-12-212020-06-242020-05-112018-05-092017-05-092017-03-242015-06-05
总股本(股) 423,620,992401,866,704401,866,704239,206,372224,000,000160,000,000160,000,000160,000,000120,000,00050,000,000
 流通股(股) 401,866,704401,866,704397,000,665224,000,000224,000,000160,000,00053,980,00040,000,000--
  流通A股(股) 401,866,704401,866,704397,000,665224,000,000224,000,000160,000,00053,980,00040,000,000--
  流通B股(股) ----------
  流通H股(股) ----------
  境外流通股(股) ----------
 限售A股(股) 21,754,288-4,866,03915,206,372--106,020,000120,000,000120,000,00050,000,000
 限售B股(股) ----------
 限售H股(股) ----------
 三板A股(股) ----------
 三板B股(股) ----------
限售股份(股) 21,754,288-4,866,03915,206,372--106,020,000120,000,000120,000,00050,000,000
 国家持股(股) ----------
 国有法人持股(股) ----------
 其他内资持股合计(股) 20,857,025-4,866,03915,206,372--106,020,000114,000,000114,000,00047,500,000
  其中:境内法人持股 16,653,347--10,753,078--6,696,00012,444,00012,444,0005,185,000
     其他境内自然人持股 4,203,678-4,866,0394,453,294--99,324,000101,556,000101,556,00042,315,000
 高管持股(股) ----------
 外资持股合计(股) 897,263------6,000,0006,000,0002,500,000
  其中:境外法人持股 897,263------6,000,0006,000,0002,500,000
     境外自然人持股 ----------
股本变动原因 增发A股上市网下配售股份上市转增股上市增发A股上市转增股上市首发限售股份上市首发限售股份上市首发A股上市上市前股本上市前股本
公告日期 2023-02-072022-06-162022-05-202020-12-232020-06-162020-04-302018-05-032017-05-082017-03-242015-06-05
变动日期 2023-02-032022-06-212022-05-272020-12-212020-06-242020-05-112018-05-092017-05-092017-03-242015-06-05

前瞻产业研究院